Industry Musings

Drug pricing: A new prescription

Read the full article on BostonGlobe.comWHAT WOULD happen if a company invented a drug that, taken once, cured a major disease like diabetes or Alzheimer’s, which affect millions of Americans? The answer: Our health care system could not afford it, even…

Next GenDrugs

Pfizer_Greenstreet-214x300

Looking at the long-term horizon, the innovative medicines and vaccines of tomorrow will likely come from a broad spectrum of sources and geographies, enabled by collaborations, alliances and partnerships. No one entity working in isolation will be sufficient to achieve…

Protecting Boston’s biotech status

Read the full article on bostonglobe.com EAT LUNCH at Legal Seafood in Kendall Square any weekday, and you are likely to be surrounded by biomedical scientists from academia and biopharmaceutical companies. You might find the occasional information technology worker, but they…

Boston’s blooming biotech ecosystem

Read the full article on bostonglobe.com ONLY A few years ago, very few investors were interested in biotech. How quickly things change. Last year was the most active for biotechnology IPOs since 2000, with 38 biotech companies selling themselves on Wall…